Worthington Financial Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.02M Buy
849
+65
+8% +$66.4K 0.84% 42
2026
Q1
$721K Hold
784
0.62% 53
2025
Q4
$843K Buy
+784
New +$750K 0.75% 42

Other funds holding LLY

Worthington Financial Partners's LLY Position: Q2 2026 in Review

Worthington Financial Partners increased its Eli Lilly (LLY) stake by 8.3% in Q2 2026, buying an estimated $66.4K and bringing the position to 849 shares worth $1.02M. The position accounts for 0.84% of the portfolio, ranked #42.

Worthington Financial Partners first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,598 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Worthington Financial Partners held 849 shares of Eli Lilly worth $1.02M as of Q2 2026.
  • Worthington Financial Partners bought 65 Eli Lilly shares in Q2 2026, an estimated $66.4K.
  • Eli Lilly made up 0.84% of Worthington Financial Partners's portfolio in Q2 2026, its #42 holding.
  • Worthington Financial Partners first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,598 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Worthington Financial Partners's 13F filing for Q2 2026, filed 21 Jul 2026.